Table 4.
Characteristic | Odds ratio (95% CI) |
P-value |
---|---|---|
Survival to 12 monthsb | ||
Acquired heart disease | 0.014 | |
No | Reference | |
Yes | 0.30 (0.11, 0.78) | |
Gastrointestinal condition | 0.031 | |
No | Reference | |
Yes | 0.38 (0.15, 0.92) | |
Minimum Lactate (mmol/L)c | 0.64 (0.49, 0.84) | 0.001 |
Survival to 12 months with VABS-II decreased ≤ 15 points from baselined,e | ||
Gastrointestinal condition | 0.022 | |
No | Reference | |
Yes | 0.21 (0.06, 0.80) | |
Minimum Lactate (mmol/L)c | 0.68 (0.48, 0.97) | 0.035 |
Open-chest cardiac massage | 0.036 | |
No | Reference | |
Yes | 2.57 (1.06, 6.22) | |
Treatment Assigned | 0.053 | |
Hypothermia | 0.41 (0.17, 1.01) | |
Normothermia | Reference | |
Survival to 12 months with VABS-II ≥ 70d,f | ||
Gastrointestinal condition | 0.006 | |
No | Reference | |
Yes | 0.17 (0.05, 0.60) | |
Minimum Lactate (mmol/L)c | 0.78 (0.61, 0.99) | 0.038 |
Models include variables available through THAPCA day 2. Day of randomization is day 0.
Modeling is based on the 139 complete records in which all potential predictors and the outcome are non-missing.
Time interval is from 2 hours before to 48 hours after the start of the temperature management intervention.
VABS-II is Vineland Adaptive Behavior Scales, Second Edition.
Modeling is based on the 142 complete records in which all potential predictors and the outcome are non-missing.
Modeling is based on the 122 complete records in which all potential predictors and the outcome are non-missing.